
Opinion|Videos|November 19, 2025
Enhancing Support and Care Coordination in mCRC
Panelists discuss how support networks and coordinated care are essential for delivering third-line metastatic colorectal cancer therapies effectively in the community.
Advertisement
Episodes in this series

Panelists stress the importance of support structures, including guidance from academic institutions, professional networks, and patient advocacy groups, in expanding access to third-line therapies.
They note that effective coordination among oncologists, pharmacists, and other providers is vital to ensure safe and seamless care transitions for patients.
This collaborative approach helps optimize patient outcomes while reducing barriers to therapy initiation and adherence.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
2
5 Things to Know About the FDA's Peptide Reversal
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South
5




